首页 | 本学科首页   官方微博 | 高级检索  
     


Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature
Authors:Matteo Brunelli  Erminia Manfrin  Keith Miller  Albino Eccher  Stefano Gobbo  Daniela Reghellin  Marco Chilosi  rea Remo  Guido Martignoni  Fabio Menestrina  and Franco Bonetti
Affiliation:Department of Pathology, University of Verona, Verona, Italy;and
UK National External Quality Assessment Scheme for Immunocytochemistry &ISH, University College London, London, UK
Abstract:Sister Mary Joseph's nodule (SMJN) involving the umbilicus can often be a clinical sign of metastatic cancer, but rarely cancer originating from the breast. We report a rare case of umbilical metastases from breast cancer and reviewed the literature. A 54-year-old woman was referred to a pre-surgery clinic for an examination of an umbilical nodule. The patient had a history of ductal breast carcinoma. Cytological smear from fine needle aspiration showed epithelial neoplastic cells resembling those of breast carcinoma. Neoplastic cells from tissue were positive for cytokeratin 8–18, estrogen and progesterone receptor and negative for E-cadherin and had a low proliferative index. Her-2/neu immunodetection showed a 2+ equivocal positive rate, but Her-2/neu gene amplification was found on the cytological smear by fluorescence in situ hybridization analysis. Similar results were obtained within a tissue section. Concordant findings have been obtained when comparing the recent American Society of Clinical Oncology/College of American Pathologists scoring system. Fine needle aspiration from the SMJN is a useful tool for the diagnosis of metastatic breast cancer. Furthermore, the predictive biomarkers for tumors of the breast, hormonal receptors and Her-2/neu not only assist with the identification of the source of the metastatic disease but also provide clinical information for patient management.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号